Pharmacogenetics of human cytosolic sulfotransferases
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Cytosolic sulfotransferases (SULTs) are phase II detoxification enzymes that are involved in the biotransformation of a wide variety of structurally diverse endo- and xenobiotics, including many therapeutic agents and endogenous steroids. Single-nucleotide polymorphisms (SNPs) in SULTs have functional consequences on the translated protein. For the most part, these SNPs are fairly uncommon in the population, but some, most notably for SULT isoform 1A1, are commonly found and have been associated with cancer risk for a variety of tumor sites and also with response to therapeutic agents. SNPs in the hydroxysteroid sulfotransferase, SULT2A1, have been identified in African-American subjects and influence the ratio of plasma DHEA:DHEA-S. This modification could potentially influence cancer risk in steroidogenic tissues. SNPs in many SULTs are ethnically distributed, another factor that could influence SULT pharmacogenetics. Finally, genetic variation has also been identified in 3'-phosphoadenoside 5'-phosphosulfate synthetase (PAPPS), the enzymes responsible for producing the obligatory cosubstrate for all sulfotransferases. Taken together, this variability could substantially influence the disposition of drugs metabolized by SULTs. Elucidation of the basis and effect of variability in sulfation could greatly impact individualized therapy in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“African-Americans have a high rate of polymorphisms in SULT2A1 apparently influencing plasma ratios of DHEA: DHEAS, which may correlate with the risk of prostatic and other cancers (603).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [603]
Citations
Cites
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129 · cited 1×
“Tamoxifen has been the gold standard of endocrine therapy for breast cancer since the 1970s (1985; 1986; Mariotto et al., 2002) and its use has contributed significantly to the decline in breast cancer mortality (Love et al., 1992).”
BackgroundSulfotransferases in the bioactivation of xenobiotics
Glatt, H. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00202-7 · Cited by 354 · cited 1×
“To date, at least 11 different SULT enzymes have been identified (reviewed in Glatt, 2000).”
BackgroundThe effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Raftogianis, R. B., Wood, T. C., Otterness, D. M., Van Loon, J. A., & Weinshilboum, R. M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7466 · Cited by 305 · cited 1×
“These SNPs were in linkage disequilibrium with each other and with an SNP at 638, which is responsible for an aminoacid change from arginine to histidine at residue 213 (Raftogianis et al., 1997; Ozawa et al., 1998).”
BackgroundTyrosine Sulfation and the Secretory Pathway
Huttner, W. B. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002051 · Cited by 263 · cited 1×
“SULTs involved in Phase II biotransformation of endoand xenobiotics are cytosolic, although there are membrane bound SULTs that are responsible for catalysing the sulfation of protein tyrosyl residues and polysaccharides (Huttner, 1988; Hashimoto and Hirschberg, 1992).”
BackgroundGenotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
Wegman, P., Vainikka, L., Stål, O., Nordenskjöld, B., Skoog, L., Rutqvist, L.-E., & Wingren, S. (2005) · Breast Cancer Research · doi:10.1186/bcr993 · Cited by 243 · cited 1×
“A subsequent study in the context of a clinical trial also indicated the same trend of better overall survival associated with the SULT1A1*1 allele (Wegman et al., 2005) in patients treated with tamoxifen.”
ResultAdjuvant Chemotherapy for Breast Cancer
BLOMQVIST, C. P. (1985) · JAMA · doi:10.1001/jama.1985.03360240073038 · Cited by 237
Pharmacogenetics of Sulfotransferase
Nagata, K., & Yamazoe, Y. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.159 · Cited by 215 · cited 1×
“SULT pharmacogenetics have been the subject of two recent reviews (Nagata and Yamazoe, 2000; Glatt and Meinl, 2004).”
BackgroundKhetawat, G., Faraday, N., Nealen, M. L., Vijayan, K. V., Bolton, E., Noga, S. J., & Bray, P. F. (2000) · Blood · doi:10.1182/blood.v95.7.2289 · Cited by 210
Parker, C. R. (1999) · Steroids · doi:10.1016/s0039-128x(99)00046-x · Cited by 201 · cited 1×
“Humans synthesize large amounts of DHEA-sulfate during fetal development and after adrenarche (Parker, 1999).”
Background
Research works printed but not linked: 2
- Falany CN, Wheeler J, Oh TS, Falany JL . (1994b). J Steroid Biochem Mol Biol 48: 369–375. · DOI · Paper page
- Wilborn T, Lang N, Smith M, Meleth S, Falany C . (2005). J Steroid Biochem Mol Biol, in press.
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Nebert, D. W., & Dalton, T. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2015 · Cited by 958
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
“intestinal epithelial cells contain a host of cytosolic SULTs, among which are members of the phenol SULT subfamily (SULT1) that are responsible for catalyzing the transfer of a sulfonyl group from 39-phosphoadenosine 59-phosphosulfate to a wide variety of phenolic xenobiotics (Eisenhofer et al., 1999; Nowell and Fala…”
BackgroundThe role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids
Cassidy, A., & Minihane, A.-M. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.136051 · Cited by 508
“with altered drugs responses and sex-steroid concentrations (18, 43).”
BackgroundCaraco, Y., Blotnick, S., & Muszkat, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100316 · Cited by 360
Turesky, R. J., & Le Marchand, L. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200135s · Cited by 337
The role of drug metabolizing enzymes in clearance
Di, L. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.876006 · Cited by 206
“Genetic polymorphism is known for SULT1A1, 1A2, 1A3, 1C2, 2A1, 2A3 and 2B1 [98].”
BackgroundDrug metabolism alterations in nonalcoholic fatty liver disease
Merrell, M. D., & Cherrington, N. J. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.577781 · Cited by 181
“Drugmetabolizing SULTs are cytosolic and belong to SULT1 and SULT2 families (Nowell and Falany, 2006).”
BackgroundEFSA Panel on food contact materials, E. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1829 · Cited by 162
Interindividual differences in phytochemical metabolism and disposition
Lampe, J. W., & Chang, J. H. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.05.003 · Cited by 139
Interindividual differences in response to plant-based diets: implications for cancer risk
Lampe, J. W. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.26736d · Cited by 133
“Single-nucleotide polymorphisms in SULT1A1 and SULT2A1 are common and have been associated with altered response to therapeutic agents and sex steroid concentrations, respectively [reviewed by Nowell and Falany (43)].”
Androgen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“ratios of DHEA:DHEAS, which may correlate with risk of prostatic and other cancers [116].”
BackgroundAdrenal Androgens and Androgen Precursors-Definition, Synthesis, Regulation and Physiologic Actions
Turcu, A., Smith, J. M., Auchus, R., & Rainey, W. E. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140006 · Cited by 113
Bessone, F., Dirchwolf, M., Rodil, M. A., Razori, M. V., & Roma, M. G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14952 · Cited by 102
“phen, albuterol, terbutaline, and methyldopa being some examples.(293) SULT1A2 is among the genes downregulated in human NASH.”
BackgroundJiang, W., & Hu, M. (2012) · RSC Advances · doi:10.1039/c2ra01369j · Cited by 106
Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure
Dewey, F. E., Perez, M. V., Wheeler, M. T., Watt, C., Spin, J. M., Langfelder, P., Horvath, S., Hannenhalli, S. S., Cappola, T. P., & Ashley, E. A. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.941757 · Cited by 103
Xanthones in Mangosteen Juice Are Absorbed and Partially Conjugated by Healthy Adults
Chitchumroonchokchai, C., Riedl, K. M., Suksumrarn, S., Clinton, S. K., Kinghorn, A. D., & Failla, M. L. (2012) · Journal of Nutrition · doi:10.3945/jn.111.156992 · Cited by 82
“For example, polymorphisms in xenobiotic metabolizing enzymes and transporters are known to influence the absorption and biotransformation of drugs and phytochemical compounds (31,32).”
BackgroundThe Gate That Governs Sulfotransferase Selectivity
Cook, I. T., Wang, T., Almo, S. C., Kim, J., Falany, C. N., & Leyh, T. S. (2012) · Biochemistry · doi:10.1021/bi301492j · Cited by 79
Self-citationLiao, Y., Liu, S., Jiang, Y., Hu, C., Zhang, X., Cao, X., Xu, Z., Gao, X., Li, L., Zhu, J., et al. (2016) · Genes & Genomics · doi:10.1007/s13258-016-0474-7 · Cited by 88
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
Bluth, M. H., & Li, J. (2011) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s18861 · Cited by 93
“Functional SNPs in SULTs that are associated with altered enzymatic activity have potential to influence therapeutic response and to modify cancer susceptibility.(8,9) One widely studied”
Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
Dezentjé, V. O., Guchelaar, H., Nortier, J. W. R., van de Velde, C. J. �., & Gelderblom, H. A. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2006 · Cited by 80
“Sulfotransferase 1A1 is considered the primary sulfotransferase responsible for the sulfation of 4-hydroxytamoxifen (17, 18) and endoxifen (19, 20).”
BackgroundXenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective
Wallace, B. D., & Redinbo, M. R. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.740049 · Cited by 73
“…SULTs, GSTs, as well as hydrolases and acetyltransferases, CAR and PXR are capable of regulating ~90% of all phase II metabolism (Wells et al., 2004; Evans and Relling, 1999; Bélanger et al., 2003; Nowell and Falany, 2006; Glatt, 2000; Pool-Zobel, 2005; Haimeur et al., 2004; Weinshilboum, 2006).”
Salman, E. D., Kadlubar, S. A., & Falany, C. N. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025767 · Cited by 69
Self-citationKapoor, M., Chao, M. J., Johnson, E. C., Novikova, G., Lai, D., Meyers, J. L., Schulman, J., Nürnberger, J. I., Porjesz, B., Liu, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25392-y · Cited by 77
PhRMA White Paper on ADME Pharmacogenomics
Williams, J. A., Andersson, T., Andersson, T. B., Blanchard, R. L., Behm, M. O., Cohen, N., Edeki, T. I., Franc, M. A., Hillgren, K. M., Johnson, K. J., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008319329 · Cited by 69
“Functionally significant pharmacogenetic variation has been identified in several SULT genes.(242,249,250) This section focuses on genetic variation in the human SULT1A1 gene as this enzyme is most relevant to the metabolism of small-molecule drugs.”
BackgroundLadumor, M. K., Bhatt, D. K., Gaedigk, A., Sharma, S., Thakur, A., Pearce, R. E., Leeder, J. S., Bolger, M. B., Singh, S., & Prasad, B. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086462 · Cited by 70
Krämer, S. D., & Testa, B. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890214 · Cited by 72
Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1)
Huang, J., Bathena, S. P., Tong, J., Roth, M. E., Hagenbuch, B., & Alnouti, Y. (2010) · Xenobiotica · doi:10.3109/00498250903514607 · Cited by 58
“SULTs are divided into families and subfamilies based on the similarity of their amino acid sequence (Nowell & Falany 2006).”
BackgroundStearns, V., & Rae, J. M. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000896 · Cited by 65
SULT genetic polymorphisms: physiological, pharmacological and clinical implications
Kurogi, K., Rasool, M. I., Alherz, F. A., Daibani, A. A. E., Bairam, A. F., Abunnaja, M. S., Yasuda, S., Wilson, L. J., Hui, Y., & Liu, M. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1940952 · Cited by 57
“Like many other genes, single nucleotide polymorphisms (SNPs) occur for genes encoding the SULTs [8–12], and, significantly, SULT SNPs have been shown to be ethnically distributed [56].”
BackgroundGene polymorphisms in bladder cancer
Franekova, M., Halášová, E., Bukovska, E., Ľupták, J., & Dobrota, D. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.10.011 · Cited by 54
“Single nucleotide polymorphisms (SNPs) are airly uncommon in the population, but some, most notably or SULT isoform 1A1, are commonly found and have been ssociated with cancer risk for a variety of tumor sites, and lso with response to therapeutic agents [46].”
BackgroundIsvoran, A., Peng, Y., Ceauranu, S., Schmidt, L., Nicot, A. B., & Miteva, M. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103349 · Cited by 53
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier
Ho, H. T. B., Dahlin, A., & Wang, J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00154 · Cited by 46
“Sulfation is important in xenobiotic activation/suppression and in posttranslational modification of secreted or membrane-bound proteins and could modify protein–protein interactions involved in leukocyte adhesion, homeostasis, and receptor-mediated signaling (Nowell and Falany, 2006; Sasaki, 2011).”
BackgroundTian, X., Huo, X., Dong, P., Wu, B., Wang, X., Wang, C., Liu, K., & Ma, X. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.010 · Cited by 47
Ginsberg, G., Guyton, K. Z., Johns, D. O., Schimek, J., Angle, K., & Sonawane, B. R. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408441003742895 · Cited by 51
High Accuracy in Silico Sulfotransferase Models
Cook, I. T., Wang, T., Falany, C. N., & Leyh, T. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510974 · Cited by 46
“The human cytosolic SULTs comprise a small (13-member) enzyme family that catalyzes transfer of the sulfuryl moiety (SO3) from 3 -phosphoadenosine 5 -phosphosulfate (PAPS) to the hydroxyls and primary amines of thousands of recipients: metabolites, drugs, and other xenobiotics (4).”
BackgroundSelf-citationPharmacogenetics of Drugs Used in the Treatment of Cancers
Franczyk, B., Rysz, J., & Gluba-Brzózka, A. (2022) · Genes · doi:10.3390/genes13020311 · Cited by 51
Bowen, J. M., Gibson, R. J., Tsykin, A., Stringer, A. M., Logan, R. M., & Keefe, D. M. K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22895 · Cited by 50
Human PAPS Synthase Isoforms Are Dynamically Regulated Enzymes with Access to Nucleus and Cytoplasm
Schröder, E., Gebel, L., Eremeev, A. A., Morgner, J., Grum, D., Knauer, S. K., Bayer, P., & Mueller, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029559 · Cited by 42
“Other sulphotransferases are crucial for phase II detoxification of xenobiotics during biotransformation [4].”
BackgroundSulfonation, an underexploited area: from skeletal development to infectious diseases and cancer
Leung, A. W. Y., Backstrom, I., & Bally, M. B. (2016) · Oncotarget · doi:10.18632/oncotarget.10046 · Cited by 47
Pharmacogenomics of anticoagulants: steps toward personal dosage
Daly, A. K. (2009) · Genome Medicine · doi:10.1186/gm10 · Cited by 49
Cholesterol and oxysterol sulfates: Pathophysiological roles and analytical challenges
Sanchez, L. D., Pontini, L., Marinozzi, M., Sanchez-Aranguren, L. C., Reis, A., & Dias, I. H. K. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15227 · Cited by 44
“The SULT2A1 isoform is highly expressed in human liver, foetal adrenal glands, adult adrenal cortex, and small intestine (Nowell & Falany, 2006; Thomae, Eckloff, Freimuth, Wieben, & Weinshilboum, 2002).”
BackgroundSulfotransferase gene copy number variation: pharmacogenetics and function
Hebbring, S. J., Moyer, A. M., & Weinshilboum, R. M. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184710 · Cited by 42
“The SULT family of Phase II conjugating enzymes has, like the CYPs, been the subject of intense pharmacogenetic studies (Glatt, 2000b; Glatt et al., 2001; Coughtrie, 2002; Glatt and Meinl, 2004; Weinshilboum and Adjei, 2005; Nowell and Falany, 2006).”
BackgroundGoodarzi, M. O., Antoine, H. J., & Azziz, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2600 · Cited by 38
Detection of clostebol in sports: Accidental doping?
de la Torre, X., Colamonici, C., Iannone, M., Jardines, D., Molaioni, F., & Botrè, F. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2951 · Cited by 38
Fischer, J. J., Michaelis, S., Schrey, A. K., Graebner, O. Y., Glinski, M., Dreger, M., Kroll, F. K., & KOESTER, H. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp236 · Cited by 39
“ST2A1 and ST2A2 belong to the group of cytosolic sulfotransferases, phase II detoxification enzymes involved in the biotransformation of a wide variety of structurally diverse endo-and xenobiotics, including many therapeutic agents and endogenous steroids (Nowell and Falany, 2006 ).”
BackgroundDetection and characterization of clostebol sulfate metabolites in Caucasian population
Balcells, G., Pozo, Ó. J., Garrostas, L., Esquivel, A., Matabosch, X., Kotronoulas, A., Joglar, J., & Ventura, R. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.03.028 · Cited by 38
“However, inter-ethnic variations of the metabolizing enzymes can cause large differences in the excretion of AAS conjugates [17,25].”
BackgroundGenetics of androgen metabolism in women with infertility and hypoandrogenism
Shohat-Tal, A., Sen, A., Barad, D. H., Kushnir, V. A., & Gleicher, N. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.64 · Cited by 38
Metabolic Pathways Involved in 2-Methoxyestradiol Synthesis and Their Role in Preeclampsia
Pérez‐Sepúlveda, A., España-Perrot, P. P., Norwitz, E. R., & Illanes, S. E. (2013) · Reproductive Sciences · doi:10.1177/1933719113477483 · Cited by 36
Structure, dynamics and selectivity in the sulfotransferase family
Leyh, T. S., Cook, I. T., & Wang, T. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.835625 · Cited by 36
Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White?
De, T., Park, C. S., & Perera, M. A. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021154 · Cited by 36
3′-Phosphoadenosine 5′-Phosphosulfate Allosterically Regulates Sulfotransferase Turnover
Wang, T., Cook, I. T., & Leyh, T. S. (2014) · Biochemistry · doi:10.1021/bi501120p · Cited by 34
“6 Recent studies of the molecular basis of SULT substrate speci fi city reveal that SULTs extensively utilize a conserved, dynamic 30-residue active-site “ cap ” in selecting their substrates.”
Mercer, K. E., Apostolov, E. O., da Costa, G. G., Yu, X., Lang, P. Y., Roberts, D. W., Davis, W., Basnakian, A. G., Kadlubar, F. F., & Kadlubar, S. A. (2010) · PubMed · Cited by 41
Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies
Argikar, U. A., Gomez, J., Ung, D., Parkman, H. P., & Nagar, S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033357 · Cited by 32
“Genetic variability in human SULTs is well understood (Nowell and Falany, 2006), and identification of specific SULT isozymes that catalyze MCP sulfation in future studies will shed light on the role of SULT pharmacogenetics in variable MCP metabolism.”
BackgroundMorgan Rouprêt, A., Cancel‐Tassin, G., Compérat, É., Fromont, G., Sibony, M., Molinié, V., Allory, Y., Triau, S., Champigneulle, J., Gaffory, C., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0361 · Cited by 31
“The formalin-fixed, paraffin-embedded primary UUTUCCs of all patients were retrieved and genomic DNA was extracted from 40-”
BackgroundInfluentialWong, S. Q., Tan, K. H., Carey, K. T., Fukushima, A., Tiganis, T., & Cole, T. J. (2009) · Endocrinology · doi:10.1210/en.2009-0590 · Cited by 31
Genome-wide analysis and environmental response profiling of SOT family genes in rice (Oryza sativa)
Chen, R., Jiang, Y., Dong, J., Zhang, X., Xiao, H., Xu, Z., & Gao, X. (2012) · Genes & Genomics · doi:10.1007/s13258-012-0053-5 · Cited by 30
Sanchez‐Spitman, A., Dezentjé, V. O., Swen, J. J., Moes, D. J. A. R., Gelderblom, H. A. J., & Guchelaar, H. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4923-7 · Cited by 28
The structure of the catechin-binding site of human sulfotransferase 1A1
Cook, I. T., Wang, T., Girvin, M. E., & Leyh, T. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613913113 · Cited by 28
“J Steroid BiochemMol Biol 114(1-2):113–119.”
BackgroundInfluentialMarto, N., Morelló, J., Monteiro, E. C., & Pereira, S. A. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1335749 · Cited by 32
“Although some studies have shown that SULT1A1 platelet enzymatic activity varies between man and woman, in liver cytosols no sex-related difference in SULT1A1 activity was demonstrated (Nowell and Falany 2006).”
BackgroundInfluentialThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
The Allosteric Binding Sites of Sulfotransferase 1A1
Cook, I. T., Wang, T., Falany, C. N., & Leyh, T. S. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061887 · Cited by 27
“SULT1A1, the focus of the current study, has a remarkably broad substrate spectrum (Nowell and Falany, 2006; Berger et al., 2011), which allows it to scan, and selectively modify, the scores of endogenous metabolites and xenobiotics that pass through hepatocyte cytosols.”
BackgroundSelf-citationTuresky, R. J. (2010) · Advances in molecular toxicology · doi:10.1016/s1872-0854(10)04002-6 · Cited by 26
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
Ferraldeschi, R., & Newman, W. G. (2010) · Pharmaceuticals · doi:10.3390/ph3041122 · Cited by 25
“for the sulphation of 4-hydroxytamoxifen and endoxifen [48,49].”
BackgroundHelland, T., Alsomairy, S., Lin, C., Søiland, H., Mellgren, G., & Hertz, D. L. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030201 · Cited by 26
Mechanism of sulfotransferase pharmacogenetics in altered xenobiotic metabolism
Chen, B.-H., Wang, C.-C., Hou, Y.-H., Mao, Y.-C., & Yang, Y. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1045486 · Cited by 30
“Several studies have demonstrated that disposition of drugs metabolized by SULTs may play a role in the development of breast, endometrial, colorectal and prostate cancers [23,24].”
BackgroundGleicher, N., Kushnir, V. A., Darmon, S. K., Wang, Q., Zhang, L., Albertini, D. F., & Barad, D. H. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.004 · Cited by 24
Gleicher, N., Kushnir, V. A., Weghofer, A., & Barad, D. H. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0158-9 · Cited by 25
“Though accurate differentiation is not always possible, it is generally accepted that low dehydroepiandrosterone sulfate (DHEAS), almost exclusively produced by the zona reticularis of adrenals, in association with low testosterone levels, strongly suggests adrenal origin of low androgen levels [9–11].”
BackgroundIsoform-specific therapeutic control of sulfonation in humans
Cook, I. T., Wang, T., & Leyh, T. S. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.010 · Cited by 24
“The preceding examples highlight the potential of SULT inhibition in treating human disease; yet, to our knowledge, there are no therapeutics that target sulfuryl-transfer – a situation due, in part, to the challenges associated with selectively inhibiting a single member of ahighly sequence- and structurally-conserve…”
Rondini, E. A., Fang, H., Runge‐Morris, M., & Kocarek, T. A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055673 · Cited by 22
Lee, H., Wang, Q., Yang, F., Tao, P., Li, H., Huang, Y. C., & Li, J. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1403 · Cited by 22
“In addition, SULT1A1 can also catalyze the biotransformation of 2-methoxyestradiol (2MeE 2 ) at physiological concentrations (Nowell et al. , 2006).”
Design and Interpretation of Human Sulfotransferase 1A1 Assays
Wang, T., Cook, I. T., & Leyh, T. S. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068205 · Cited by 22
“In humans, the activities of the cytosolic sulfotransferases (SULTs) account for approximately one third of phase 2 metabolism (Blanchard et al., 2004; Nowell and Falany, 2006).”
BackgroundTetrahydrobiopterin regulates monoamine neurotransmitter sulfonation
Cook, I. T., Wang, T., & Leyh, T. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704500114 · Cited by 22
Unravelling sex-specific BPA toxicokinetics in children using a pediatric PBPK model
Deepika, D., Sharma, R. P., Schuhmacher, M., Sakhi, A. K., Thomsen, C., Chatzi, L., Vafeiadi, M., Quentin, J., Slama, R., Gražulevičienė, R., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114074 · Cited by 22
Hao, D., Xiao, P., & Chen, S. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4062-9 · Cited by 21
Gessner, L., Thevis, M., Rothschild, M. A., & Jübner, M. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3355 · Cited by 20
Cytosolic Aryl Sulfotransferase 4A1 Interacts with the Peptidyl Prolyl Cis-Trans Isomerase Pin1
Mitchell, D. J., & Minchin, R. F. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055442 · Cited by 19
“…catalyze the transfer of a sulfonyl moiety from the cofactor 5 -phosphoadenosine-3 - phosphosulfate (PAPS) to various acceptor molecules, which results in a more hydrophilic metabolite prone to rapid renal excretion (Gamage et al., 2006; Nowell and Falany, 2006; Hempel et al., 2007).”
BackgroundEffect of Environmental Exposure and Pharmacogenomics on Drug Metabolism
Banerjee, B. D., Kumar, R., Thamineni, K. L., Shah, H. K., Thakur, G., & Sharma, T. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200110153304 · Cited by 19
Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1
Wang, T., Cook, I. T., & Leyh, T. S. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00401 · Cited by 17
“SULTs are expressed in highly specific tissue and developmental patterns (5-7) and play critical”
BackgroundTuresky, R. J. (2008) · Wiley eBooks · doi:10.1002/9780470430101.ch2c · Cited by 17
Relationship of SULT1A1 copy number variation with estrogen metabolism and human health
Liu, J., Zhao, R., Ye, Z., Frey, A. J., Schriver, E., Snyder, N. W., & Hebbring, S. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.08.017 · Cited by 17
“As a physiological negative control, free dehydroepiandrosterone (DHEA) and sulfated dehydroepiandrosterone (DHEA-S) were analyzed, as these compounds are generated primarily by adrenal synthesis and undergo sulfation by SULT2A1 [32].”
BackgroundInnocenti, F., Ramírez, J., Obel, J. C., Xiong, J., Mirkov, S., Chiu, Y., Katz, D. A., Carr, R. A., Zhang, W., Das, S., et al. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283623e81 · Cited by 16
Golgi-resident PAP-specific 3′-phosphatase-coupled sulfotransferase assays
Prather, B., Ethen, C. M., Machacek, M. E., & Wu, Z. L. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.01.003 · Cited by 16
“Cytosolic sulfotransferases, commonly designated as SULTs, are mainly involved in modifying steroids, neurotransmitters and xenobiotics [2–4], and play roles in drug detoxification [5,6].”
BackgroundLiu, T.-A., Bhuiyan, S., Snow, R., Yasuda, S., YASUDA, T., YANG, Y., WILLIAMS, F., Liu, M.-C., Suiko, M., & Carter, G. (2008) · Aquatic Toxicology · doi:10.1016/j.aquatox.2008.06.005 · Cited by 16
“The current study is part of an overall effort to establish a zebrafish model for systematic studies on the ontogeny, cell type/tissue/organ-specific distribution, as well as the physiological involvement of the SULTs, a group of Phase II detoxifying enzymes commonly found among vertebrates (Nowell and Falany, 2006).”
BackgroundA versatile polyacrylamide gel electrophoresis based sulfotransferase assay
Wu, Z. L., Ethen, C. M., Larson, S., Prather, B., & Jiang, W. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-11 · Cited by 15
“Along with P450 enzymes, SULTs play important roles in drug detoxification [4,5].”
BackgroundDuffel, M. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00418-8 · Cited by 16
Cholesterol Sulfate: Pathophysiological Implications and Potential Therapeutics
Yu, X., Lei, S., Shen, Y., Liu, T., Li, J., Wang, J., & Su, Z. (2025) · Biomolecules · doi:10.3390/biom15050646 · Cited by 15
“Cytoplasmic SULTs are involved in the metabolism of endogenous substances (such as hormones and neurotransmi tt ers) and exogenous substances (such as drugs), whereas membrane-bound SULTs mainly participate in the sulfation of tyrosine residues [10].”
Dieudonné, A.-S., Lambrechts, D., Claes, B., Vandorpe, T., Wildiers, H. P. M. W., Timmerman, D., Billen, J., Leunen, K., Amant, F. C., Berteloot, P., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0463-5 · Cited by 14
“Sulfotransferases and UDP-glucuronosyltransferases are important for increasing the solubility and facilitate the excretion of tamoxifen and its metabolites [8, 9].”
BackgroundAromatic Amines and Heterocyclic Aromatic Amines: From Tobacco Smoke to Food Mutagens
Turesky, R. J. (2010) · Wiley eBooks · doi:10.1002/9783527630110.ch7 · Cited by 14
The loss of phenol sulfotransferase 1 in hepatocellular carcinogenesis
Yeo, M., Na, Y. M., Kim, D. K., Kim, Y. B., Wang, H. J., Lee, J. A., Cheong, J. Y., Lee, K. J., Paik, Y., & Cho, S. W. (2009) · PROTEOMICS · doi:10.1002/pmic.200900721 · Cited by 14
Cao, X., Liao, Y., Rong, S., Hu, C., Zhang, X., Chen, R., Xu, Z., Gao, X., Li, L., & Zhu, J. (2016) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2015.1136237 · Cited by 14
Complex roles for sulfation in the toxicities of polychlorinated biphenyls
Duffel, M. W., & Lehmler, H. (2024) · Critical Reviews in Toxicology · doi:10.1080/10408444.2024.2311270 · Cited by 15
“…between genotype and phenotype for SNVs relevant to the expression and activity of human SULTs have been reviewed (Nagata and Yamazoe 2000; Glatt and Meinl 2004; Weinshilboum and Adjei 2005; Nowell and Falany 2006; Daniels and Kadlubar 2013; Kurogi et al. 2021; Yi et al. 2021; Isvoran et al. 2022).”
BackgroundPharmacogenomics: a tool for improving cancer chemotherapy
Monzó, M., Navarro, A., Ferrer, G., & Artells, R. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0263-0 · Cited by 25
“In breast cancer, SULT1A1*/2* polymorphisms have been related to outcome with tamoxifen [50], and in acute myeloblastic leukaemia, and SULT1C2 Asp5Glu has been associated with relapse and disease-free survival [51].”
BackgroundDrug Metabolism: Significance and Challenges
Prakash, C., & Vaz, A. D. N. (2008) · Wiley eBooks · doi:10.1002/9780470409107.ch1 · Cited by 13
Associations between peripheral androgens and cortisol in infertile women
Gleicher, N., Seier, K., Kushnir, V. A., Weghofer, A., Wu, Y.-G., Wang, Q., Albertini, D. F., & Barad, D. H. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.01.004 · Cited by 12
Slanař, O., Hronová, K., Bartošová, O., & Šíma, M. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1865310 · Cited by 12
Heterocyclic Aromatic Amines: Potential Human Carcinogens
Turesky, R. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-61737-995-6_5 · Cited by 15
A simple method to measure sulfonation in man using paracetamol as probe drug
Marto, N., Morelló, J., Antunes, A. M. M., Lopes, S. A., Monteiro, E. C., & Pereira, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-88393-3 · Cited by 11
Controlling Sulfuryl-Transfer Biology
Cook, I. T., Wang, T., Wang, W., Kopp, F., Wu, P., & Leyh, T. S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.04.009 · Cited by 11
“Small-molecule sulfuryl-transfer in humans is largely determined by the thirteen SULT isoforms encoded in the genome (Nowell and Falany, 2006).”
Metadata
- Authors
- Nowell, S., & Falany, C. N.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Nowell, S
- Falany, C N
- Venue
- Oncogene
- Published
- 2006-03-13
- Volume
- 25
- Issue
- 11
- Pages
- 1673-1678
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2058380077
- Semantic Scholar
- 4a231f71813b6ba42e0f4860c32817dcb237908f
- Cited by
- 158
- References
- 49
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 11 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 15
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- cytosolic sulfotransferases, SULT1A1, SULT2A1, hydroxysteroid sulfotransferase, single nucleotide polymorphisms, genetic variation, cancer risk, drug metabolism, sulfation, 3'-phosphoadenosine 5'-phosphosulfate, personalized treatment, phase II enzymes
- MeSH terms
- Antineoplastic Agents, Black or African American, Ethnicity, Humans, Isoenzymes, Neoplasms, Pharmacogenetics, Sulfotransferases, Arylsulfotransferase, Xenobiotics, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.